Drs. Guentchev and Tuettenberg share senior authorship.
Mutant IDH1 inhibits PI3K/Akt signaling in human glioma
Version of Record online: 25 APR 2014
© 2014 American Cancer Society
Volume 120, Issue 16, pages 2440–2447, August 15, 2014
How to Cite
Birner, P., Pusch, S., Christov, C., Mihaylova, S., Toumangelova-Uzeir, K., Natchev, S., Schoppmann, S. F., Tchorbanov, A., Streubel, B., Tuettenberg, J. and Guentchev, M. (2014), Mutant IDH1 inhibits PI3K/Akt signaling in human glioma. Cancer, 120: 2440–2447. doi: 10.1002/cncr.28732
We are grateful to Andreas von Deimling, Pieter Wesseling, and Herbert Budka for critical discussions and support. We thank Gerda Ricken and Milena Moneva for excellent technical assistance. The kind support of David Reuss is highly appreciated.
- Issue online: 5 AUG 2014
- Version of Record online: 25 APR 2014
- Manuscript Accepted: 31 MAR 2014
- Manuscript Revised: 8 MAR 2014
- Manuscript Received: 3 FEB 2014
Additional supporting information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.